SOURCE: Corporate Profile LLC

Corporate Profile LLC

November 08, 2010 10:52 ET

Corporate Profile's Publishes IPOFinancial's Report on Rexahn Pharmaceuticals, Inc.

NEW YORK, NY--(Marketwire - November 8, 2010) -  Corporate Profile's financial website announces report by IPOFinancial on Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN). 

To view report go to: or 

About features Gene Marcial, Ray Dirks and Goldman Small Cap Research. The website and newsletter provide readers and subscribers fresh, original, and highly informative ideas and market commentary. Content is focused on what is going on in the stock market and on Wall Street.

About Corporate is a broadcasting website where Fashion meets Finance, merging two mainstream industries results in the unique platform for today's hottest tips and market info.


For 20 years, has been recognized as the oldest independent specialty research firm serving the IPO and Secondary market in the US. Through its wholly-owned subsidiary, IPOfn MicroCap Corp, companies that have lost their research sponsorship from the sell-side can now be represented once again, with institutional quality research. Either the featured company of the reports, or a third party pays a fee for coverage. can be reached at - 10 East Willow Street - Millburn, NJ 07041 (973) 379-5100

Safe Harbor Disclaimer
Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectation.